Literature DB >> 1712509

Novel epitopes on the CA50-carrying antigen: chemical and immunochemical studies.

C Johansson1, O Nilsson, D Baeckström, E L Jansson, L Lindholm.   

Abstract

Novel tumour-associated epitopes showing elevated levels in sera from patients with colon carcinoma were studied by means of monoclonal antibodies with respect to co-expression with the tumour-associated epitope CA50 on the cancer antigen (CanAg) glyco-conjugate complex. Co-expression of the different epitopes and CA50 was found on CanAg both from COLO 205 spent medium and sera from patients with colorectal cancer. In a few sera from patients with non-mucinous ovarian tumours, the CanAg complex was also found to express the CA125 epitope. The chemical characterisation showed that all of the novel epitopes on CanAg were of carbohydrate nature, and the results may suggest a structural relationship between several of them.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712509     DOI: 10.1159/000217701

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

1.  Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.

Authors:  Xue-Qin Yang; Chuang Chen; Chun-Wei Peng; Shao-Ping Liu; Yan Li
Journal:  Med Oncol       Date:  2011-05-07       Impact factor: 3.064

2.  Sialyl-Lewis x and Sialyl-Lewis a are associated with MUC1 in human endometrium.

Authors:  N A Hey; J D Aplin
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

3.  The transcripts of the apomucin genes MUC2, MUC4, and MUC5AC are large and appear as distinct bands.

Authors:  D Baeckström; G C Hansson
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

4.  Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9.

Authors:  O Nilsson; C Johansson; B Glimelius; B Persson; B Nørgaard-Pedersen; A Andrén-Sandberg; L Lindholm
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

5.  Comparative study of CA242 and CA19-9 in chronic pancreatitis.

Authors:  N Furuya; S Kawa; O Hasebe; M Tokoo; K Mukawa; S Maejima; H Oguchi
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

6.  The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.

Authors:  G Lindmark; R Bergström; L Påhlman; B Glimelius
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

7.  Preoperative serum levels of CEA and CA 242 in colorectal cancer.

Authors:  M Carpelan-Holmström; C Haglund; P Kuusela; H Järvinen; P J Roberts
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

8.  Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.

Authors:  S Kawa; M Tokoo; O Hasebe; K Hayashi; H Imai; H Oguchi; K Kiyosawa; S Furuta; T Homma
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

9.  Serum tumor markers in pancreatic cancer-recent discoveries.

Authors:  Felix Rückert; Christian Pilarsky; Robert Grützmann
Journal:  Cancers (Basel)       Date:  2010-06-02       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.